| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 12/03/2009 | US20090298851 Phenyl piperazine compounds, pharmaceutical composition comprising the same and use thereof |
| 12/03/2009 | US20090298850 Treatment for Neurological and Mental Disorders |
| 12/03/2009 | US20090298849 Materials and Methods Relating to the Induction of Apoptosis in Target Cells |
| 12/03/2009 | US20090298845 Piperazinyl derivatives as modulators of chemokine receptor activity |
| 12/03/2009 | US20090298841 serotonin receptor modulators such as 8-(4-Methyl-piperazin-1-yl)-3-phenylsulfonylquinoline, used for treating obesity, nervous system disorders such as dementia, schizophrenia and Alzheimer's disease, and as cognition activators |
| 12/03/2009 | US20090298837 poly(ADP-ribose) polymerase (PARP) inhibitors such as 9-[(Hydrozinooxy)carbonyl]-2,7-dihydro-6-methoxy 3H-pyrido-[4,3,2-de]phthalazin-3-one, used for treating neuron tissue damage resulting from ischemia and reperfusion injury, depression, inflammatory bowel disorders, arthritis, gout, pain and sepsis |
| 12/03/2009 | US20090298825 Bicycloheteroaryl Compounds as P2x7 Modulators and Uses Thereof |
| 12/03/2009 | US20090298819 Compositions, Synthesis, And Methods Of Using Piperazine Based Antipsychotic Agents |
| 12/03/2009 | US20090298817 Anti-amnesic compounds and pharmaceutical compositions comprising them |
| 12/03/2009 | US20090298813 Use of neuroprotective compounds in obtaining medicaments intended for the treatment of neurodegenerating diseases |
| 12/03/2009 | US20090298809 5-ht3 receptor modulators, methods of making, and use thereof |
| 12/03/2009 | US20090298794 Hydroxy substituted thieno pyrimidinones as melanin concentrating hormone receptor-1 antagonists |
| 12/03/2009 | US20090298781 Compounds for the inhibition of apoptosis |
| 12/03/2009 | US20090298775 Method of measuring neprilysin activity |
| 12/03/2009 | US20090298759 C-Reactive Protein and Its Use to Treat Systemic Lupus Erythematosus and Related Conditions |
| 12/03/2009 | US20090298755 Novel Chimeric Analgesic Peptides |
| 12/03/2009 | US20090297601 Dosage form time-lagged of drugs for the therapy of insomnia |
| 12/03/2009 | US20090297580 Spinal nucleus pulposus implant |
| 12/03/2009 | US20090297574 Flexable spirally-rolled polymer tube for monitoring and treatment of brain injuries |
| 12/03/2009 | US20090297573 Identifying and Modulating Molecular Pathways that Mediate Nervous System Plasticity |
| 12/03/2009 | US20090297538 Neurotoxic oligomers |
| 12/03/2009 | US20090297511 Prevention and treatment of amyloidogenic disease |
| 12/03/2009 | US20090297505 Abeta binding molecules |
| 12/03/2009 | US20090297494 Diagnostic and treatment of a mental disorder |
| 12/03/2009 | US20090297485 Compositions and methods for treating psychiatric and neurodegenerative disorders |
| 12/03/2009 | US20090297443 Labeled ALPHA4BETA2 Ligands and Methods Therefor |
| 12/03/2009 | CA2729812A1 Therapeutic agent for alzheimer's disease |
| 12/03/2009 | CA2726264A1 Hydroxy substituted thieno pyrimidinones as melanin concentrating hormone receptor-1 antagonists |
| 12/03/2009 | CA2725897A1 Novel substituted pyrazoles, 1,2,4-oxadiazoles, and 1,3,4-oxadiazoles |
| 12/03/2009 | CA2725788A1 Calcium/sodium salt of inositol tripyrophosphate as an allosteric effector of hemoglobin |
| 12/03/2009 | CA2725545A1 Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases |
| 12/03/2009 | CA2725484A1 Percutaneously absorbable preparation |
| 12/03/2009 | CA2725307A1 Novel benzothiophene oxide derivative and salt thereof |
| 12/03/2009 | CA2725111A1 Substituted carbinol compound having a cyclic linker |
| 12/03/2009 | CA2724502A1 Adhesive preparation containing donepezil, and package of the same |
| 12/03/2009 | CA2721665A1 Compounds including an anti-inflammatory pharmacore and methods of use |
| 12/03/2009 | CA2721065A1 Phenoxypyridinylamide derivatives and their use in the treatment of pde4 mediated disease states |
| 12/03/2009 | CA2720531A1 Amide derivatives as positive allosteric modulators and methods of use thereof |
| 12/03/2009 | CA2719127A1 Polysubstituted derivatives of 2-heteroaryl-6-phenyl-imidazo[l,2-a] pyridines, and preparation and therapeutic use thereof |
| 12/03/2009 | CA2719125A1 Polysubstituted 2-aryl-6-phenyl-imidazo[l,2-a] pyridine derivatives, and preparation and therapeutic use thereof |
| 12/03/2009 | CA2719118A1 Polysubstituted derivatives of 6-heteroaryl-imidazo[l,2-a]pyridines, and preparation and therapeutic use thereof |
| 12/03/2009 | CA2718953A1 Polysubstituted derivatives of 2-aryl-6-phenyl-imidazo[l,2-.alpha.] pyridines, and preparation and therapeutic use thereof |
| 12/02/2009 | EP2128267A2 Methods of evaluating phosphatase inhibitors |
| 12/02/2009 | EP2128265A1 Method for glycosylation of flavonoid |
| 12/02/2009 | EP2128257A2 Mutation of the parkin gene, compositions, methods and uses |
| 12/02/2009 | EP2128154A1 Benzimidazole compound and pharmaceutical use thereof |
| 12/02/2009 | EP2128137A1 Selective m4 receptor antagonist and its medical use |
| 12/02/2009 | EP2127653A1 Agent for treatment of multiple sclerosis |
| 12/02/2009 | EP2127651A1 Stabilized medicinal composition containing donepezil, method of producing the same and method for stabilization |
| 12/02/2009 | EP2127648A1 Pharmaceutical formulations of amyloid inhibiting compounds |
| 12/02/2009 | EP2125873A1 Novel therapeutics based on tau/microtubule dynamics |
| 12/02/2009 | EP2125801A1 The use of 7-azaindoles in the inhibition of c-jun n-terminal kinase |
| 12/02/2009 | EP2125787A1 Derivatives of n-(heteroaryl)-1-heteroaryl-1h-indol-2-carboxamids, preparation thereof and therapeutic use thereof |
| 12/02/2009 | EP2125785A1 Indoles |
| 12/02/2009 | EP2125779A1 Polymorphs of a mglur5 receptor antagonist |
| 12/02/2009 | EP2125753A1 Fused heterocyclic compounds having crf antagonistic activity |
| 12/02/2009 | EP2125725A1 Compounds of formula (i) as serine protease inhibitors |
| 12/02/2009 | EP2125721A1 Aryl-substituted sulfonamides for the treatment of cognitive or food ingestion related disorders |
| 12/02/2009 | EP2125720A1 Indole and benzothiophene compounds as modulators of the histamine h3 receptor |
| 12/02/2009 | EP2125702A1 Levodopa dimethyl-substituted diester prodrugs, compositions, and methods of use |
| 12/02/2009 | EP2125683A1 3-benzofuranyl-4-indolyl maleimides as potent gsk3 inhibitors for neurogenerative disorders |
| 12/02/2009 | EP2125023A2 Soluble forms of inclusion complexes of histone deacetylase inhibitors and cyclodextrins, their preparation processes and uses in the pharmaceutical field |
| 12/02/2009 | EP2125015A1 Method for the treatment of amyloidoses |
| 12/02/2009 | EP2124985A2 Methods and compositions for treating neuropathies |
| 12/02/2009 | EP2124965A1 Methods for preventing and treating neurodegenerative disorders |
| 12/02/2009 | EP2124961A2 Novel composition based on cholest-4-ene-3-one oxime |
| 12/02/2009 | EP2124957A1 Methods of treating mood disorders |
| 12/02/2009 | EP2124951A1 5-cyan0-4- (pyrrolo ý2, 3b¨pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors |
| 12/02/2009 | EP2124950A1 Treatment of pain with naloxone |
| 12/02/2009 | EP2124947A1 Dosage regimen for comt inhibitors |
| 12/02/2009 | EP2124934A2 Cosmetic and pharmaceutical applications of n-acetylhydroxyproline |
| 12/02/2009 | EP2124933A1 Tosylate salt of a therapeutic compound and pharmaceutical compositions thereof |
| 12/02/2009 | EP2124928A1 Use of cis-epoxyeicosatrienoic acids and inhibitors of soluble epoxide hydrolase to treat conditions mediated by pbr, cb2, and nk2 receptors |
| 12/02/2009 | EP2124908A1 Compounds and uses thereof |
| 12/02/2009 | EP2124552A1 Extended release pharmaceutical formulations of s-adenosylmethionine |
| 12/02/2009 | EP1863785B1 Novel thiophene sulfoximines for treating complement-mediated diseases and conditions |
| 12/02/2009 | EP1861360B1 Pyrrolidine derivatives as histamine h3 receptor antagonists |
| 12/02/2009 | EP1606284B1 Compositions useful as protein kinase inhibitors |
| 12/02/2009 | EP1581249B1 G-csf for use in the treatment of amyotrophic lateral sclerosis |
| 12/02/2009 | EP1542984B1 Methods of purifying cannabinoids from plant material |
| 12/02/2009 | EP1414459B1 Oral dosage form comprising a therapeutic agent and an adverse-effect agent |
| 12/02/2009 | EP1349841B1 Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto |
| 12/02/2009 | EP1322748B1 Stem cell differentiation-inducing promoter |
| 12/02/2009 | EP1248804B2 Recombinant antibodies to human interleukin-1 beta |
| 12/02/2009 | CN101595100A Heterocyclic-substituted piperidine as ORL-1 ligands |
| 12/02/2009 | CN101595099A Crystalline duloxetine hydrochloride |
| 12/02/2009 | CN101595098A 1,2,4-triazole derivatives as sigma receptor inhibitors |
| 12/02/2009 | CN101594909A IRAK modulators for treating an inflammatory condition, cell proliferative disorder, immune disorder |
| 12/02/2009 | CN101594868A A pharmaceutical composition having antipsychotic, antidepressant or antiepiieptic activity with reduced side effect |
| 12/02/2009 | CN101594860A Adam inhibitor |
| 12/02/2009 | CN101594856A Agent and method for preventing and treating intoxication by alcohol-containing liquids and alcohol substitutes |
| 12/02/2009 | CN101594855A Muscarinic agonists to treat impulse control disorders |
| 12/02/2009 | CN101591642A Method for inducing proliferation and differentiation of olfactory stem cells by co-culture of two kinds of olfactory cells |
| 12/02/2009 | CN101591641A Method for inducing differentiation of olfactory stem cells by olfactory ensheathing cell culture supernatant |
| 12/02/2009 | CN101591386A Polypeptide capable of inhibiting excitable and toxic damages and use thereof |
| 12/02/2009 | CN101591377A Aminoacyl-phenylalanyl-tryptophan or derivative, synthetic method and application thereof |
| 12/02/2009 | CN101591375A Compound with analgesic activity, preparation method and application thereof |
| 12/02/2009 | CN101591337A Compound formed by splicing ferulic acid and matrine compound and application thereof |
| 12/02/2009 | CN101591330A Sertindole crystal form and preparation method thereof |
| 12/02/2009 | CN101591321A Method for preparing 5,6,7,4'-tetrahydroxyflavone and application of 5,6,7,4'-tetrahydroxyflavone in medicaments |